These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2180858)

  • 1. [Unusual manifestation of scleroderma of the trunk].
    Hackel H; Zillikens D; Lechner W; Burg G
    Hautarzt; 1990 Feb; 41(2):91-3. PubMed ID: 2180858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nuclear antibodies as serologic markers in progressive systemic scleroderma].
    Lakomek HJ; Guldner HH; Bautz FA; Goerz G; Kind P; Mensing H; Krüskemper HL
    Hautarzt; 1987 Feb; 38(2):63-9. PubMed ID: 3106261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
    Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Centromere antibodies and antibodies against Scl 70 nucleoprotein in progressive systemic scleroderma. Diagnostic and prognostic significance].
    Meurer M; Scharf A; Luderschmidt C; Braun-Falco O
    Dtsch Med Wochenschr; 1985 Jan; 110(1):8-14. PubMed ID: 3880700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary manifestation of progressive systemic scleroderma: prognostic value of centromere antibodies and antibodies to Scl-70 nucleoprotein].
    Behr J; König G; Meurer M; Krieg T
    Pneumologie; 1990 Jun; 44(6):822-5. PubMed ID: 2381889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.
    Giordano M; Valentini G; Migliaresi S; Picillo U; Vatti M
    J Rheumatol; 1986 Oct; 13(5):911-6. PubMed ID: 3546686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
    Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
    Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticentromere antibodies and other antinuclear antibodies in progressive systemic sclerosis].
    Rojas C; Silva MC; Pérez L; Ruiz F
    Rev Med Chil; 1985 May; 113(5):409-14. PubMed ID: 3912881
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticentromere antibodies--clinical correlates.
    Wade JP; Sack B; Schur PH
    J Rheumatol; 1988 Dec; 15(12):1759-63. PubMed ID: 3265957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-Scl-70 antibody and anti-nucleolar antibody in patients with systemic sclerosis].
    Kinoshita M
    Nihon Rinsho; 1990 Feb; 48 Suppl():494-6. PubMed ID: 2355569
    [No Abstract]   [Full Text] [Related]  

  • 12. [The Scl-70 antibody and its clinical significance].
    Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski TP; Jablonska S
    Dermatol Monatsschr; 1989; 175(3):133-47. PubMed ID: 2653887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of anti-Scl-70 antibody and its clinical significance in progressive systemic sclerosis.
    Jiang M; Song QF; Wang SZ; Yuan X; Zhang NZ
    Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(4):247-9. PubMed ID: 3124097
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological markers of the subsets of systemic scleroderma and its overlap.
    Jabłońska S; Błaszczyk M; Jarzabek-Chorzelska M; Chorzelski T; Kołacińska-Strasz Z
    Arch Immunol Ther Exp (Warsz); 1991; 39(4):381-90. PubMed ID: 1821614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scleroderma: DR antigens, autoantibodies and clinical manifestations.
    Alarcón GS; McCarty GA; Lanyon P; Phillips RM; Acton RT; Barger BO
    Clin Exp Rheumatol; 1987; 5(4):317-21. PubMed ID: 3326691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antinuclear antibodies in progressive systemic sclerosis].
    Sepúlveda C; Palma S; Guzmán L; Bravo M
    Rev Med Chil; 1986 Aug; 114(8):731-6. PubMed ID: 3554436
    [No Abstract]   [Full Text] [Related]  

  • 18. Scl 70 antibody--a specific marker of systemic sclerosis.
    Jarzabek-Chorzelska M; Blaszczyk M; Jablonska S; Chorzelski T; Kumar V; Beutner EH
    Br J Dermatol; 1986 Oct; 115(4):393-401. PubMed ID: 3535866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The PM-Scl (polymyositis-scleroderma) autoantibody and its nucleolar fluorescence pattern].
    Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski TP; Jablonska S
    Dermatol Monatsschr; 1989; 175(8):479-83. PubMed ID: 2676628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of anti-centromere and anti-Scl 70 antibodies in scleroderma. Report of two cases.
    Ruffatti A; Calligaro A; Ferri C; Bombardieri S; Gambari PF; Todesco S
    J Clin Lab Immunol; 1985 Apr; 16(4):227-9. PubMed ID: 3874966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.